Granules India Ltd Share Price

Overview

Granules India Ltd share price is currently ₹829.65, down by - ₹10.31 (1.23%) from its previous closing price of ₹839.96. The share price has declined -0.08% over the past month and gained 81.81% over the past year. The stock's 52-week low and high are ₹452.52 and ₹902.87, respectively. Granules India Ltd has a market capitalisation of ₹ 21,260.00 Cr. The share price was last updated on 25 Aug 2026, 03:54 PM IST.

Granules India Ltd

GRANULES

₹0.00

- ₹10.31

1.23%

Healthcare

₹0.00(%)1D

Updated: 25 Aug 2026, 03:54:16 pm IST

Market Data

Open Price

₹841.88

Prev. Close

₹839.96

₹825.60

Day Low

₹841.88

Day High

₹452.52

52 Week Low

₹902.87

52 Week High

HealthcarePharmaceuticals & Drugs

CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

30.76

Sector PE

42.03

PB Ratio

4.36

Sector PB

5.83

EPS

26.97

Dividend Yield

0.28

Today's Volume

598.748 K

5 Day Avg. Volume

401.927 K

PEG Ratio

1.91

Market Cap.

₹ 21,260.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 175% at ₹1.75/Share	30-Jul-2026	30-Jul-2026
DividendsFinal Dividend of 150% at ₹1.5/Share	31-Jul-2025	31-Jul-2025

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
Old Bridge Focused Fund - Regular Plan - Growth	16.50 Lac	16.50 Lac no change
Aditya Birla Sun Life Value Fund - Regular Plan - Growth	14.03 Lac	14.03 Lac no change
Aditya Birla Sun Life Small Cap Fund - Growth	11.07 Lac	11.07 Lac no change
Aditya Birla Sun Life Multi-Cap Fund - Regular Plan - Growth	10.31 Lac	10.31 Lac no change
Sundaram Aggressive Hybrid Fund - Growth	6.84 Lac	8.76 Lac (28.09%)

Show all holdings

About Granules India Ltd 👋

Granules India Limited is an India-based pharmaceutical manufacturing company. The Company operates through its pharmaceutical products segment. Its geographical segments include within India and outside India. The Company has a presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). It produces and supplies Paracetamol, Metformin, Guaifenesin, and Methocarbamol APIs. It has over 10 manufacturing facilities, approximately eight of which are located in India and two in the United States. The Company sells its products in global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific, and India. Its subsidiaries include Granules USA Inc and Granules Europe Limited. It also owns Senn Chemicals AG, a contract development and manufacturing organization (CDMO) specializing in peptide development and manufacturing.